Hyperthermia Therapy Global Market Report 2026

Hyperthermia therapy is a therapeutic medical technique that applies carefully controlled heat to elevate the temperature of targeted tissues for treatment purposes. It is intended to stimulate beneficial biological responses by enhancing cellular function, increasing blood circulation, and improving the effectiveness of various therapeutic interventions. Hyperthermia therapy employs specialized equipment to deliver accurate and controlled heat to designated areas while minimizing harm to the surrounding healthy tissues.

The primary therapy categories of hyperthermia therapy comprise local hyperthermia therapy, regional hyperthermia therapy, and whole-body hyperthermia therapy. Local hyperthermia therapy involves targeted heating methods that elevate the temperature of specific tumors or affected tissues to improve therapeutic effectiveness while limiting damage to surrounding healthy tissues. These therapies are administered using external surface devices, interstitial or intracavitary devices, deep tissue applicators, and monitoring and thermometry systems, while incorporating modalities such as radiofrequency hyperthermia, microwave hyperthermia, and ultrasound hyperthermia. They are applied in oncology treatment, radiosensitization, chemosensitization, and palliative care, and are utilized by hospitals, cancer treatment centers, specialty clinics, research institutes, and other healthcare facilities.

Tariffs are influencing the hyperthermia therapy market by increasing the expense of imported medical equipment, heating applicators, electronic components, and advanced thermometry systems essential for accurate thermal treatment procedures. This is affecting equipment acquisition and technology adoption, particularly in regions dependent on imported healthcare technologies such as North America, Europe, and Asia-Pacific. Device categories including deep tissue applicators, interstitial or intracavitary devices, and monitoring and thermometry systems are experiencing the greatest impact because of their reliance on specialized components and international supply chains. However, tariffs are also encouraging local manufacturing, regional sourcing strategies, and investment in domestic medical device production, strengthening long-term market resilience.

The hyperthermia therapy market research report is one of a series of new reports from The Business Research Company that provides hyperthermia therapy market statistics, including hyperthermia therapy industry global market size, regional shares, competitors with a hyperthermia therapy market share, detailed hyperthermia therapy market segments, market trends and opportunities, and any further data you may need to thrive in the hyperthermia therapy industry. This hyperthermia therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperthermia therapy market size has grown strongly in recent years. It will grow from $0.25 billion in 2025 to $0.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing prevalence of cancer cases, increasing adoption of hyperthermia as an adjunct cancer therapy, rising demand for minimally invasive treatment options, expanding oncology infrastructure, increasing clinical research activities for thermal therapy applications.

The hyperthermia therapy market size is expected to see strong growth in the next few years. It will grow to $0.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing integration of precision medicine approaches, rising demand for personalized oncology treatments, growing adoption of advanced thermometry systems, expanding use of combination treatment strategies, increasing investment in next-generation hyperthermia devices. Major trends in the forecast period include increasing adoption of advanced heat delivery technologies, growing development of personalized hyperthermia treatment protocols, rising integration of real-time temperature monitoring systems, expansion of combination therapies with radiation and chemotherapy, increasing demand for non-invasive thermal treatment approaches.

The increasing cancer incidence is expected to drive the growth of the hyperthermia therapy market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body, which can invade surrounding tissues and interfere with normal organ functions. The rising cancer incidence is influenced by the increasing prevalence of risk factors such as aging populations, unhealthy lifestyles, and exposure to environmental hazards, resulting in a greater number of cancer cases and increasing the need for advanced diagnostic and treatment solutions. The growing prevalence of cancer is driving demand for hyperthermia therapy, as it is used in combination with chemotherapy and radiotherapy to enhance treatment effectiveness and improve patient outcomes. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based UN agency, annual new cancer cases reached 20.6 million in 2024 and are expected to increase to nearly 35 million by 2050, representing an increase of almost 70%. Therefore, the increasing cancer incidence is expected to support the growth of the hyperthermia therapy market.

Leading companies operating in the hyperthermia therapy market are increasingly prioritizing magnetic nanoparticle-mediated hyperthermia systems to advance precision cancer treatment, improve therapeutic outcomes, and expand research into minimally invasive oncology solutions. Magnetic nanoparticle-mediated hyperthermia systems utilize magnetic nanoparticles activated by alternating magnetic fields to generate localized heat within tumors, enabling targeted cancer cell destruction while minimizing damage to surrounding healthy tissues and supporting combination therapies. For example, in February 2026, Mayo Clinic, a US-based academic medical center, collaborated with New Phase Ltd., an Israel-based medical technology company, to install the first magnetic nanoparticle-mediated hyperthermia system for cancer research in the United States. The investigational system is designed to support research assessing the safety, feasibility, and potential effectiveness of magnetic nanoparticle hyperthermia in cancer treatment. It enables targeted heat-based therapy and advances clinical research. The magnetic nanoparticle-mediated hyperthermia system supports the development of innovative cancer treatment approaches and accelerates the adoption of precision hyperthermia therapy.

In October 2023, Andromedic, an Italy-based company specializing in capacitive hyperthermia devices, entered into a collaboration with Sensius to enhance the advancement of hyperthermia and thermotherapy solutions in the Italian market. Through this collaboration, Andromedic and Sensius focused on increasing the adoption of hyperthermia and thermotherapy in Italy by promoting clinical studies, collaborating with oncology organizations, and supporting the development of reimbursement frameworks. Sensius is a Netherlands-based company that develops precision hyperthermia therapy systems.

Major companies operating in the hyperthermia therapy market report are Chongqing Haifu Medical Technology Co. Ltd., RanD Biotech S.r.l., Combat Medical Ltd., Pyrexar Medical Inc., Oncotherm Kft., Celsius42 GmbH, Elmedical Ltd., Thermofield, Shanghai Huayuan Electronic Co. Ltd., Dr. Sennewald Medizintechnik GmbH, Sensius B.V., Andromedic S.r.l., innoMedicus Ltd., ThermaSolutions Inc., Von Ardenne Institut GmbH, Gamida Ltd., Yamamoto Vinita Co. Ltd., Hydrosun Medizintechnik GmbH, Verthermia

North America was the dominant region in the hyperthermia therapy market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the hyperthermia therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hyperthermia therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hyperthermia therapy market consists of revenues earned by entities by providing services such as data management services, technical support services, and post-treatment follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperthermia therapy market also includes sales of radiofrequency hyperthermia systems, microwave hyperthermia systems, capacitive hyperthermia devices, and ultrasound hyperthermia systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperthermia Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hyperthermia therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperthermia therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyperthermia therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapy Type: Local Hyperthermia Therapy; Regional Hyperthermia Therapy; Whole Body Hyperthermia Therapy
• 2) By Device: External Surface Devices; Interstitial Or Intracavitary Devices; Deep Tissue Applicators; Monitoring And Thermometry Systems
• 3) By Modality: Radiofrequency Hyperthermia; Microwave Hyperthermia; Ultrasound Hyperthermia
• 4) By Application: Oncology Treatment; Radiosensitization; Chemosensitization; Palliative Care
• 5) By End User: Hospitals; Cancer Treatment Centers; Specialty Clinics; Research Institutes; Other End Users
• Subsegments:
• 1) By Local Hyperthermia Therapy: External Hyperthermia; Interstitial Hyperthermia; Intracavitary Hyperthermia
• 2) By Regional Hyperthermia Therapy: Deep Tissue Regional Hyperthermia; Regional Perfusion Hyperthermia; Hyperthermic Intraperitoneal Chemotherapy
• 3) By Whole Body Hyperthermia Therapy: Moderate Temperature Whole Body Hyperthermia; High Temperature Whole Body Hyperthermia
• Companies Mentioned: Chongqing Haifu Medical Technology Co. Ltd.; RanD Biotech S.r.l.; Combat Medical Ltd.; Pyrexar Medical Inc.; Oncotherm Kft.; Celsius42 GmbH; Elmedical Ltd.; Thermofield; Shanghai Huayuan Electronic Co. Ltd.; Dr. Sennewald Medizintechnik GmbH; Sensius B.V.; Andromedic S.r.l.; innoMedicus Ltd.; ThermaSolutions Inc.; Von Ardenne Institut GmbH; Gamida Ltd.; Yamamoto Vinita Co. Ltd.; Hydrosun Medizintechnik GmbH; Verthermia
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.